Newsletter | November 14, 2026

11.14.26 -- Best Of October

OCTOBER'S BEST FEATURED EDITORIALS

The U.S. Clinical Trial Recruiting Pipeline – September 2026

This WhichTrial report breaks down which drug trials are growing the most and the least, drugs that are no longer being studied, and new drugs to the clinic from August to September.

What The FDA Says About Investigator Responsibilities In DCTs

Learn exactly what the FDA says about the use of healthcare providers (HCPs), telemedicine, licensing, and practice standard requirements when executing a DCT.

Can We Make Feasibility More Realistic?

Drawn from a Clinical Leader Live webinar, this article explores how sponsors can make clinical trial feasibility and enrollment forecasts more realistic by questioning data sources, examining patient and site burdens, challenging protocol assumptions, and looking beyond seemingly convincing answers from historical data and AI.

OCTOBER'S BEST INDUSTRY INSIGHTS

Initial IRB Submission: 7 Fundamentals Of Success

The initial IRB submission process can involve common challenges. To help you overcome these obstacles, discover seven fundamentals you should know about a successful initial IRB submission.

CRF Validation Best Practices: Building Reliable Clinical Trial Databases

CRF validation improves data quality and efficiency. Early planning, clear edit checks, and balance reduce rework, ease site burden, and enable more reliable, streamlined study execution.

The True Science Behind eCOA, Shaped By Patient And Site Insights

This webinar brings together patients, sites, and eCOA science to dismantle the researcher-subject hierarchy and replace it with a collaborative model.

OCTOBER'S BEST SOLUTIONS

A Strategic Partner For Your Psychedelic Research

More Than A Copilot: Agentic Clinical Monitoring In Action

Listen To Your Trial Participants — Your Research Depends On It

Connect With Clinical Leader: